ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home EGFR Resisters

More Than a Partnership: How Oncogene-Driven Patient Groups Are Mobilizing the Global Community to Drive Research

Upal Basu Roy
on: August 13, 2021In: Patient Advocacy & Survivorship
More Than a Partnership: How Oncogene-Driven Patient Groups Are Mobilizing the Global Community to Drive
            Research

It has been just over a year since we reported how oncogene-driven patient advocacy groups are disrupting the research paradigm in lung cancer.1 We have indeed come a long way […] Read more


Disrupting the Paradigm: Partnering With Oncogene-Focused Patient Groups to Propel Research

Upal Basu Roy
on: April 16, 2020In: Patient Advocacy & Survivorship
Disrupting the Paradigm: Partnering With Oncogene-Focused Patient Groups to Propel Research

Genomic alterations drive more than 60% of adenocarcinoma cases of NSCLC.1  Approximately 25% of these cases will have an oncogenic driver (EGFR, ALK, ROS1, BRAF, or NTRK) that can be […] Read more

Letter to the Editor: Patient-Driven Research

on: December 10, 2019In: Patient Advocacy & Survivorship
Letter to the Editor: Patient-Driven Research

By Jill Feldman, EGFR Resisters Co-Founder Posted: December 11, 2019   Jill Feldman I was so glad to see the article by Dr. Amy Moore on PDX models in the October […] Read more

IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy